Skip to content
2000
Volume 11, Issue 9
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

The hypothesis that tumors may originate from a rare population of cancer stem cells (CSCs) has gained tremendous popularity in recent years and is supported extensively by several pioneering works. Cancer therapies targeting CSCs have unlimited potential for relapse free survival of cancer patients. As a result, knowledge of biological pathways that govern CSCs is very important and this review is focused on the biology of CSCs with special emphasis on breast CSCs, and recent advances in therapeutic approaches targeting them.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/138945010792006843
2010-09-01
2025-01-12
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/138945010792006843
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test